Your browser is no longer supported. Please, upgrade your browser.
OPRX OptimizeRx Corporation daily Stock Chart
OptimizeRx Corporation
Index- P/E1023.08 EPS (ttm)0.01 Insider Own1.10% Shs Outstand12.53M Perf Week-14.69%
Market Cap166.65M Forward P/E45.86 EPS next Y0.29 Insider Trans- Shs Float9.29M Perf Month2.11%
Income0.20M PEG20.46 EPS next Q-0.04 Inst Own50.90% Short Float3.04% Perf Quarter36.97%
Sales21.20M P/S7.86 EPS this Y108.90% Inst Trans30.54% Short Ratio4.47 Perf Half Y-25.91%
Book/sh1.71 P/B7.78 EPS next Y181.55% ROA1.20% Target Price23.92 Perf Year195.56%
Cash/sh0.71 P/C18.72 EPS next 5Y50.00% ROE1.60% 52W Range4.29 - 18.39 Perf YTD21.24%
Dividend- P/FCF208.31 EPS past 5Y18.60% ROI1.00% 52W High-27.68% Beta1.04
Dividend %- Quick Ratio2.40 Sales past 5Y35.30% Gross Margin57.60% 52W Low210.02% ATR1.03
Employees37 Current Ratio2.40 Sales Q/Q65.00% Oper. Margin0.80% RSI (14)43.84 Volatility8.73% 7.16%
OptionableNo Debt/Eq0.00 EPS Q/Q58.10% Profit Margin1.10% Rel Volume0.89 Prev Close13.78
ShortableYes LT Debt/Eq0.00 EarningsFeb 26 AMC Payout0.00% Avg Volume63.17K Price13.30
Recom1.80 SMA20-7.76% SMA502.25% SMA2001.51% Volume56,427 Change-3.48%
Jan-03-19Initiated William Blair Outperform
Mar-20-19 08:31AM  OptimizeRx Survey Shows Providers Want to Engage with Patients on Drug Costs for Adherence and Improved Care GlobeNewswire
Mar-12-19 05:48PM  OptimizeRx Corp (OPRX) Files 10-K for the Fiscal Year Ended on December 31, 2018
Mar-10-19 12:39AM  Edited Transcript of OPRX earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-04-19 08:31AM  OptimizeRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019; Pre-Conference Webcast Available March 11 GlobeNewswire
Feb-26-19 04:01PM  OptimizeRx Reports Fourth Quarter 2018 Results; Net Revenue Up 64% to a Record $6.6 Million, Driving First Profitable Year GlobeNewswire
Feb-19-19 07:44AM  Should We Be Cautious About OptimizeRx Corporations (NASDAQ:OPRX) ROE Of 0.6%? Simply Wall St.
Feb-13-19 08:31AM  OptimizeRx Sets Fourth Quarter and Full Year 2018 Conference Call for Tuesday, February 26, 2018 at 4:30 p.m. ET GlobeNewswire
Feb-11-19 08:31AM  OptimizeRx Survey Shows Providers Believe They Have a Role in Discussing Care Costs with Patients GlobeNewswire
Feb-07-19 11:30AM  OptimizeRx Introduces OptimizeMDs, a Voice of the Physician Multi-Specialty Digital Health Panel GlobeNewswire
Feb-01-19 03:55PM  OptimizeRx partners with IllumiCare American City Business Journals
Jan-29-19 08:31AM  OptimizeRx Announces New Partnership with Health IT Pioneer lllumiCare GlobeNewswire
Jan-23-19 10:54AM  Does Market Volatility Impact OptimizeRx Corporations (NASDAQ:OPRX) Share Price? Simply Wall St.
Jan-21-19 10:33PM  Edited Transcript of OPRX earnings conference call or presentation 5-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Dec-18-18 08:52AM  OptimizeRx Announces Pricing of Public Offering of Common Stock GlobeNewswire -17.76%
Dec-17-18 04:01PM  OptimizeRx Announces Proposed Public Offering of Common Stock GlobeNewswire
Nov-30-18 11:00AM  OptimizeRx Joins MSCI USA Microcap Index GlobeNewswire
Nov-28-18 01:06PM  OptimizeRx to Present at 11th Annual LD Micro Main Event on December 4-6, 2018 ACCESSWIRE
Nov-16-18 07:37AM  Do Institutions Own OptimizeRx Corporation (NASDAQ:OPRX) Shares? Simply Wall St.
Nov-15-18 08:40AM  Recent Analysis Shows Construction Partners, OptimizeRx, OncoMed Pharmaceuticals, Issuer Direct, Red Violet, and Golden Minerals Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire -7.83%
Nov-07-18 08:31AM  OptimizeRx to Ring Nasdaq Closing Bell on Friday, November 16 GlobeNewswire +9.39%
Nov-05-18 04:01PM  OptimizeRx Reports Third Quarter 2018 Results; Net Revenue Up 75% to a Record $5.4 Million, Driving $0.02 EPS GlobeNewswire
Oct-29-18 10:31AM  OptimizeRx (OPRX) Q3 Earnings Preview: What to Look Out For Zacks
Oct-25-18 11:52AM  OptimizeRx to Present at ROTH Technology Corporate Access Day on November 14, 2018 GlobeNewswire
Oct-23-18 08:31AM  OptimizeRx Sets Third Quarter 2018 Conference Call for Monday, November 5, 2018 at 4:30 p.m. ET GlobeNewswire
Oct-17-18 08:30AM  OptimizeRx Acquires CareSpeak Communications GlobeNewswire +10.19%
Oct-11-18 08:23AM  Are OptimizeRx Corporations (NASDAQ:OPRX) Interest Costs Too High? Simply Wall St. -7.85%
Oct-10-18 08:31AM  OptimizeRx Invited to Co-Host Plenary Session at Digital Pharma East on October 17, 2018 GlobeNewswire -14.43%
Oct-09-18 08:30AM  MicroCap Review Magazine Fall 2018 Issue Now Available ACCESSWIRE
Oct-08-18 09:44AM highlights: OptimizeRX, Verso, BioSpecifics Technologies and Luxfer Holdings Zacks
Oct-05-18 07:48AM  4 Stocks With Recent Price Strength to Maximize Your Gains Zacks
Sep-27-18 08:31AM  OptimizeRx Partners with Medicom Health to Bring Automated Medication Savings Directly to Patients at Hospitals Nationwide GlobeNewswire
Sep-12-18 09:00AM  OptimizeRx Launches ROI Guarantee to Pharmaceutical Manufacturers GlobeNewswire
Aug-29-18 08:31AM  OptimizeRx to Participate at Lake Street Capital Markets Best Ideas Growth Conference on September 13, 2018 GlobeNewswire
Aug-21-18 01:50PM  Edited Transcript of OPRX earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
OptimizeRx Corporation provides digital health messaging to the pharmaceutical industry. The company offers a direct channel for pharmaceutical companies to communicate with healthcare providers. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies; and brand messaging services, such as various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages that could be targeted by specialty, diagnostic code, and other criteria. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. It has a strategic partnership with Patient Connect to deliver real-time messaging at point-of-care in Europe. OptimizeRx Corporation is based in Rochester, Michigan.